American Herbal Products Association (AHPA) > News

CO Gov Jared Polis charts course for CBD and hemp innovation at sold-out AHPA Supplement Congress

USDA and FDA officials share key information for companies selling hemp-CBD in dietary supplements

Colorado Governor Jared Polis rallied more than 200 hemp farmers, manufacturers, producers, retailers, and industry professionals during his keynote address to the American Herbal Products Association (AHPA) Hemp-CBD (cannabidiol) Supplement Congress held earlier this month.

CA Prop 65 Guidance for Hemp Products

Regulatory and liability implications of Proposition 65 for hemp and hemp-derived products

AHPA has published Guidance on California Proposition 65 and Hemp Products to educate the hemp industry about the regulatory and liability implications of Proposition 65 for hemp and hemp-derived products, including cannabidiol (CBD), sold in the State of California.

AHPA Hemp-CBD Status Report

Updated to cover recent FDA and USDA actions

To help the herbal products industry understand the evolving regulatory landscape for hemp and hemp-derived cannabidiol (CBD) products, AHPA has updated its free Hemp-CBD Status Report to include recent actions taken by the Food and Drug Administration (FDA) and the U.S. Department of Agriculture (USDA).

AHPA urges FDA to protect consumers by quickly clarifying hemp-CBD regulations

Existing supplement and food regulations are sufficiently robust for hemp-derived ingredients

The American Herbal Products Association (AHPA) urged the Food and Drug Administration (FDA) last week to protect consumers by quickly taking specific actions to clarify the regulatory status of hemp and hemp-derived ingredients used in dietary supplements and foods that contain cannabidiol (CBD).

IADSA update on international supplement regulations

IADSA July 2019 Newsflash

China considers adding 5 functional ingredients, including reishi powder and spirulina, to its food raw materials directory, and changes to permitted health food function claims, in this issue of the IADSA Newsflash.

AHPA recommends FDA implement policies to support innovation

The American Herbal Products Association (AHPA) submitted extensive and specific policy recommendations on July 15 to the Food and Drug Administration (FDA) to support responsible dietary supplement innovation while preserving and strengthening FDA’s ability to efficiently and effectively protect the public from unsafe and unlawful products.

Revised Hemp-CBD Status Report

How hemp and CBD companies are impacted by passage of the Farm Bill

Congress passed a Farm Bill in 2018 that included historic provisions to legalize hemp, the low THC cultivars of the Cannabis sativa L. species. This landmark legislation changes how hemp and hemp-derived products like cannabidiol (CBD) are regulated in the U.S. To help the herbal products industry understand the new regulatory landscape, AHPA has expanded this Status Report and to answer industry questions about the new legal landscape.

Sen. Wyden urges HHS-FDA to issue interim final rule for lawful use of CBD in food and dietary supplements

Sen. Wyden's request aligns with AHPA's hemp-CBD advocacy

Sen. Ron Wyden (D-OR), a co-author of the hemp provisions included in the 2018 Farm Bill, sent letters to Food and Drug Administration (FDA) Commissioner Ned Sharpless and Health & Human Services (HHS) Secretary Alex Azar urging the agencies to promptly create a regulatory pathway to use cannabidiol (CBD) as a food additive and as a dietary ingredient in dietary supplements.

AHPA President Michael McGuffin presents on CA regulations that impact the supplement industry at ACI Conference

AHPA provides several resources to help navigate CA regulations

American Herbal Products Association (AHPA) President Michael McGuffin discussed significant California regulations that impact the dietary supplement industry at the American Conference Institute's (ACI's) seventh annual Legal, Regulatory, and Compliance Forum on Dietary Supplements held in New York City June 18-20.

AHPA urges USTR to exempt herbal product ingredients from proposed China tariff increases

Herbal ingredients should be excluded from tariff increases because supplements and food play important roles in the health of U.S. consumers

The American Herbal Products Association (AHPA) urged the U.S. Trade Representative (USTR) to remove herbal product ingredients from a list of Chinese goods that would be subject to a 25 percent ad valorem duty under a recent USTR proposal to increase tariffs on an estimated $300 billion worth of Chinese imports.

Alerts

Subscribe>>

AHPA Alerts

Subscribe >>

Recent News